Short Interest in Genscript Biotech Co. (OTCMKTS:GNNSF) Declines By 70.6%

Genscript Biotech Co. (OTCMKTS:GNNSF) was the target of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 549,600 shares, a drop of 70.6% from the January 31st total of 1,867,800 shares. Based on an average daily trading volume, of 200 shares, the short-interest ratio is currently 2,748.0 days.

Genscript Biotech Price Performance

Shares of GNNSF remained flat at C$1.90 during trading hours on Friday. The company has a 50-day moving average price of C$1.40 and a 200 day moving average price of C$1.41. Genscript Biotech has a 1-year low of C$1.05 and a 1-year high of C$2.05.

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.